CORRECTION article

Front. Chem., 11 January 2023

Sec. Organic Chemistry

Volume 10 - 2022 | https://doi.org/10.3389/fchem.2022.1131801

Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors

  • 1. Department of Math and Sciences, College of Humanities and Sciences, Prince Sultan University, Riyadh, Saudi Arabia

  • 2. Department of Chemistry, College of Science, King Saud University, Riyadh, Saudi Arabia

  • 3. Department of Chemistry, Faculty of Science, Suez Canal University, Ismaïlia, Egypt

  • 4. Cell Therapy Center, The University of Jordan, Amman, Jordan

  • 5. Department of Basic Medical Sciences, Faculty of Sciences, Yarmouk University, Irbid, Jordan

  • 6. KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa

  • 7. Peptide Science Laboratory, School of Chemistry and Physics, University of KwaZulu-Natal, Durban, South Africa

  • 8. CIBER-BBN (Networking Centre on Bioengineering, Biomaterials and Nanomedicine) and Department of Organic Chemistry, University of Barcelona, Barcelona, Spain

  • 9. Chemistry Department, Faculty of Science, Alexandria University, Alexandria, Egypt

In the original article, there was an error in the Affiliation for Samha Al Ayoubi2. Instead of “Samha Al Ayoubi 2”, it should be “Samha Al Ayoubi1”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

pyrazolyl-s-triazine, indole, anticancer profile, EGFR/CDK-2, apoptosis

Citation

Shawish I, Nafie MS, Barakat A, Aldalbahi A, Al-Rasheed HH, Ali M, Alshaer W, Al Zoubi M, Al Ayoubi S, De La Torre BG, Albericio F and El-Faham A (2023) Corrigendum: Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors. Front. Chem. 10:1131801. doi: 10.3389/fchem.2022.1131801

Received

26 December 2022

Accepted

30 December 2022

Published

11 January 2023

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

10 - 2022

Updates

Copyright

*Correspondence: Assem Barakat, ; Fernando Albericio, ; Ayman El-Faham,

This article was submitted to Organic Chemistry, a section of the journal Frontiers in Chemistry

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics